Search All UT System Experts

A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis

Ivan R. Schwab, M. Friedlaender, J. McCulley, S. J. Lichtenstein, C. T. Moran, Cono M. Grasso

Research output: Contribution to journal › Short survey › peer-review

Fingerprint

Dive into the research topics of 'A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis'. Together they form a unique fingerprint.